Kawanaka et al. reported decreased antithrombin III (ATIII) activity and large splenic vein diameter (SVD) are risk factors for portal vein thrombosis after splenectomy in liver cirrhosis with portal hypertension [28]. This evidence concerns the gene SERPINC1 and Portal vein thrombosis.